<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Publication:
Predictors of pulmonary hypertension after atrial septal defect closure: Impact of atrial fibrillation

dc.contributor.authorKırali, Kaan
dc.contributor.authorKaymaz, Cihangir
dc.contributor.authorKaragoz, Ali
dc.contributor.authorYılmaz, Yusuf
dc.contributor.authorKahyaoglu, Muzaffer
dc.contributor.authorCelik, Mehmet
dc.contributor.authorKup, Ayhan
dc.date.accessioned2026-10-09T21:23:42Z
dc.date.issued2022
dc.departmentYüksek İhtisas Üniversitesi
dc.description.abstractBackground:­ In this study, we aimed to evaluate the course of pulmonary artery systolic pressure, to identify factors associated with pulmonary arterial hypertension, and to determine the impact of atrial septal defect closure on clinical outcomes in long-term follow-up. Methods: Between March 2008 and August 2020, a total of 547 adult patients (193 males, 354 females; median age: 37 years; range, 27.5 to 47 years) with secundum atrial septal defect were retrospectively analyzed. Of these patients, 304 underwent percutaneous defect closure and 243 underwent isolated surgical repairs. Pulmonary arterial hypertension was defined as a non- invasively estimated pulmonary artery systolic pressure of ?40 mmHg at the final follow-up after atrial septal defect closure. Factors associated with pulmonary arterial hypertension were analyzed. Results:­ Sixty-nine (12.6%) patients presented with pulmonary arterial hypertension at the final follow-up. A total of 35 (6.4%) patients had persistent atrial fibrillation before atrial septal defect closure, and 22 of these 35 patients had pulmonary arterial hypertension during long-term follow-up. Older age at the time of atrial septal defect closure (HR: 4.76; 95% CI: 2.68-8.44; p<0.001), the presence of persistent atrial fibrillation (HR: 2.18; 95% CI: 1.21-3.91; p=0.009), and greater right ventricular basal diameter (HR: 4.78; 95% CI: 2.57-8.84; p<0.001) were found to be associated with late pulmonary arterial hypertension. Conclusion:­ The presence of persistent atrial fibrillation may be used to predict patients at higher risk for pulmonary arterial hypertension after atrial septal defect closure.
dc.identifier.doi10.5606/tgkdc.dergisi.2022.23639
dc.identifier.endpage53
dc.identifier.issn1301-5680
dc.identifier.issn2149-8156
dc.identifier.issue3
dc.identifier.startpage44
dc.identifier.trdizinid1173427
dc.identifier.urihttps://doi.org/10.5606/tgkdc.dergisi.2022.23639
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1173427
dc.identifier.urihttps://hdl.handle.net/20.500.12794/1454
dc.identifier.volume30
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofTürk Göğüs Kalp Damar Cerrahisi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR-Dizin_20260922
dc.subjectKlinik Nöroloji
dc.subjectMikrobiyoloji
dc.subjectOnkoloji
dc.subjectKalp ve Kalp Damar Sistemi
dc.titlePredictors of pulmonary hypertension after atrial septal defect closure: Impact of atrial fibrillation
dc.typeArticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1454.pdf
Size:
491.08 KB
Format:
Adobe Portable Document Format